RepurpOS

Mastocytosis with KIT D816V Mutation

Disease intelligence for Mastocytosis with KIT D816V Mutation: 1 alterations and 0 ranked therapeutics from curated public databases.

Disease overview

Alterations
1
Molecular (A)
0
Clinical (B–E)
1
Direct drugs
0
Via biomarker
0
Natural agents
0
Natural products
0
Merged ranked
0

Sources: Open Targets, ClinicalTrials.gov, PubMed Literature · Pipeline phase 6 · Updated 2026-07-10

Identifiers: —

Alterations

1 total · Types A (molecular) through E (functional)

NameTypeSubtypeDirection FrequencyEvidenceSourcesLinks
Cumulative response (4R75%) Lab / Clinical Lab value Emerging ClinicalTrials.gov

Therapeutics

Direct disease associations, biomarker-linked drugs, OSMF narrative-review natural agents, and merged ranking. Only agents with registry trials or published clinical literature are shown by default.

No therapeutics in this section.

No therapeutics in this section.

No therapeutics in this section.

Alterations and therapeutics are aggregated from public databases (Open Targets, HPO, ChEMBL, DGIdb, and others). Natural agents are candidates from OSMF narrative reviews on opensourcemed.info/chronic-disease.html — not approved treatments. This page is for research orientation only — not medical advice.